Clinical Study
A Novel Curcumin-Galactomannoside Complex Delivery System Improves Hepatic Function Markers in Chronic Alcoholics: A Double-Blinded, randomized, Placebo-Controlled Study
Figure 3
Liver toxicity markers in serum; significant difference in p values given as = p < 0.01; = p < 0.001, and ns = p > 0.05, when the CGM group is compared with that of placebo.
(a) |
(b) |
(c) |
(d) |